The Recall Desk
ModerateFDA (Devices)·Z-1368-2014·Announced 2014-04-16

LumiQuick Amphetamine Strip Recalled for Unapproved US Distribution

LumiQuick Diagnostics is recalling Amphetamine Strips shipped to US locations without approved PMA, IDE, or 510(k) clearance.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text indicates a regulatory compliance issue (unapproved distribution) rather than a specific safety hazard or reported injury, aligning with the criteria for moderate severity.

Plain-English summary

LumiQuick Diagnostics Inc. is recalling all lots of the Amphetamine Strip (Catalog number 74013). The recall was initiated because the products were shipped to US locations that do not have approved applications for Premarket Approval (PMA), Investigational Device Exemption (IDE), or 510(k) clearance.

The affected products were distributed in the states of California, Florida, New Jersey, Texas, and New York. The recall covers all lots of the product.

Consumers and healthcare providers should stop using the affected Amphetamine Strips and contact the recalling firm for further instructions.

The recalled product

Product
Amphetamine Strip; LumiQuick. Santa Clara, CA 95054

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Catalog number: 74013
  • All lots

Distribution

Distributed in 5 states:

Part of a larger recall action

This product is one of 80 recalled by LumiQuick Diagnostics Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →

Same manufacturer · LumiQuick Diagnostics Inc.

See all →